Study of Single Dose GHB16L2 Trivalent Influenza Vaccine in Healthy Adults

This study has been completed.
Sponsor:
Information provided by:
AVIR Green Hills Biotechnology AG
ClinicalTrials.gov Identifier:
NCT01369862
First received: January 4, 2011
Last updated: January 9, 2014
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
No publications provided by AVIR Green Hills Biotechnology AG

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):